Gamida Cell Ltd. - Ordinary Shares (GMDA): Price and Financial Metrics


Gamida Cell Ltd. - Ordinary Shares (GMDA)

Today's Latest Price: $5.66 USD

0.24 (4.43%)

Updated Oct 22 4:00pm

Add GMDA to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

GMDA Stock Price Chart Interactive Chart >

Price chart for GMDA

GMDA Price/Volume Stats

Current price $5.66 52-week high $7.70
Prev. close $5.42 52-week low $2.60
Day low $5.32 Volume 162,200
Day high $5.74 Avg. volume 204,468
50-day MA $4.50 Dividend yield N/A
200-day MA $4.42 Market Cap 137.10M

Gamida Cell Ltd. - Ordinary Shares (GMDA) Company Bio


Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.


GMDA Latest News Stream


Event/Time News Detail
Loading, please wait...

GMDA Latest Social Stream


Loading social stream, please wait...

View Full GMDA Social Stream

Latest GMDA News From Around the Web

Below are the latest news stories about Gamida Cell Ltd that investors may wish to consider to help them evaluate GMDA as an investment opportunity.

Gamida Cell EPS misses by $0.39

Gamida Cell (GMDA): Q2 GAAP EPS of -$0.69 misses by $0.39.Cash and cash equivalents of $88.6MPress Release...

Seeking Alpha | August 11, 2020

Gamida Cell (GMDA) to Report Q2 Earnings: What's in Store?

Gamida Cell (GMDA) will provide updates on its pipeline candidates when it releases second-quarter 2020 results.

Yahoo | July 23, 2020

Gamida Cell Announces Appointment of Michele Korfin as Chief Operating and Chief Commercial Officer

Gamida Cell announced the appointment of Michele Korfin as chief operating and chief commercial officer.

Yahoo | July 21, 2020

Has Gamida Cell (GMDA) Outpaced Other Medical Stocks This Year?

Is (GMDA) Outperforming Other Medical Stocks This Year?

Yahoo | July 20, 2020

Gamida Cell Announces Appointment of David Fox to Its Board of Directors

Gamida Cell announced that David Fox has been appointed to its board of directors as an independent member.

Yahoo | July 7, 2020

Read More 'GMDA' Stories Here

GMDA Price Returns

1-mo 36.39%
3-mo 28.34%
6-mo 36.39%
1-year 17.55%
3-year N/A
5-year N/A
YTD 31.63%
2019 -56.74%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6692 seconds.